2023
DOI: 10.3389/fonc.2023.1124459
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive investigating of MMR gene in hepatocellular carcinoma with chronic hepatitis B virus infection in Han Chinese population

Abstract: Hepatocellular carcinoma associated with chronic hepatitis B virus infection seriously affects human health. Present studies suggest that genetic susceptibility plays an important role in the mechanism of cancer development. Therefore, this study focused on single nucleotide polymorphisms (SNPs) of MMR genes associated with HBV-HCC. Five groups of participants were included in this study, which were healthy control group (HC), spontaneous clearance (SC), chronic hepatitis B group (CHB), HBV-related liver cirrh… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 59 publications
(45 reference statements)
0
1
0
Order By: Relevance
“…Several cytokines have been measured to investigate their association with the treatment response to SIRT and/or 60-day survival rates, and to evidence changed inflammation or immune dysregulation in the HCC cohort (Figure 2). The focus has been on examining key immunologic factors such as TNF-alpha and interleukins (IL-6, IL-8, IL-10, IL12p70, IL-17a, IL-18, IL-23, IL-33, IL-1beta) and interferons (IFN-alpha2, IFN-gamma) (Figure 2) [21][22][23][24][25]. We report mainly statistically significant differences here; other changes are given in Figure 2.…”
Section: Clinical Characteristics Associated With Treatment and Outcomementioning
confidence: 78%
“…Several cytokines have been measured to investigate their association with the treatment response to SIRT and/or 60-day survival rates, and to evidence changed inflammation or immune dysregulation in the HCC cohort (Figure 2). The focus has been on examining key immunologic factors such as TNF-alpha and interleukins (IL-6, IL-8, IL-10, IL12p70, IL-17a, IL-18, IL-23, IL-33, IL-1beta) and interferons (IFN-alpha2, IFN-gamma) (Figure 2) [21][22][23][24][25]. We report mainly statistically significant differences here; other changes are given in Figure 2.…”
Section: Clinical Characteristics Associated With Treatment and Outcomementioning
confidence: 78%